摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-二羟基-10,13-二甲基-3-氧代-2,6,7,8,9,11,12,14,15,16-十氢-1H-环戊二烯并[a]菲-17-基]-2-氧代乙基]己酸酯 | 3593-96-2

中文名称
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-二羟基-10,13-二甲基-3-氧代-2,6,7,8,9,11,12,14,15,16-十氢-1H-环戊二烯并[a]菲-17-基]-2-氧代乙基]己酸酯
中文别名
己酸氢化可的松
英文名称
21-hexanoyloxy-11β,17α-dihydroxypregn-4-en-3,20-dione
英文别名
hydrocortisone hexanoate;Hydrocortison capronat;Hydrocortisone caproate;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] hexanoate
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-二羟基-10,13-二甲基-3-氧代-2,6,7,8,9,11,12,14,15,16-十氢-1H-环戊二烯并[a]菲-17-基]-2-氧代乙基]己酸酯化学式
CAS
3593-96-2
化学式
C27H40O6
mdl
——
分子量
460.611
InChiKey
XZSVYVIYKBHVMV-FOMYWIRZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    33
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.81
  • 拓扑面积:
    101
  • 氢给体数:
    2
  • 氢受体数:
    6

SDS

SDS:626726517899b18f26ca91d5dfe412ee
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    氢化可的松己酸甲酯 在 Candida antarctica lipase B 作用下, 以 甲苯 为溶剂, 以90%的产率得到[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-二羟基-10,13-二甲基-3-氧代-2,6,7,8,9,11,12,14,15,16-十氢-1H-环戊二烯并[a]菲-17-基]-2-氧代乙基]己酸酯
    参考文献:
    名称:
    Lipase-catalyzed regioselective preparation of fatty acid esters of hydrocortisone
    摘要:
    A series of fatty acid derivatives of hydrocortisone has been prepared by an enzymatic methodology. Nine 21-monoacyl products and one 3,11,17-triacetyl derivative, nine of them novel compounds, were obtained in a highly regioselective way through lipase-catalyzed esterification, transesterification and alcoholysis reactions. The influence of various reaction parameters Such as acylating agent: substrate ratio, enzyme: substrate ratio. solvent, temperature and nature of acylating agent and alcohol was evaluated. Among the tested lipases. Candida antarctica lipase appeared to be the most appropriate and showed a high efficient behavior especially in a one-pot transesterification. The advantages presented by this methodology, such as mild reaction conditions and low environmental impact, make the biocatalysis a convenient way to prepare acyl derivatives of hydrocortisone. These lipophilic compounds are potential products in the pharmaceutical industry. (C) 2009 Elsevier Inc. All rights reserved.
    DOI:
    10.1016/j.steroids.2009.07.010
点击查看最新优质反应信息

文献信息

  • Use of tocopherol ascorbic adic phosphates for hemorrhoidal diseases
    申请人:Senju Pharmaceutical Co., Ltd.
    公开号:EP0661053A1
    公开(公告)日:1995-07-05
    A therapeutic agent for hemorrhoidal diseases, comprising, as an active ingredient, a diester phosphate compound of the formula (I) wherein R₁ and R₂ are the same or different and each is a hydrogen atom or a methyl, or a pharmacologically acceptable salt thereof, and a method for treating hemorrhoidal diseases, comprising administering a pharmaceutically effective amount of said diester phosphate compound or a pharmacologically acceptable salt thereof.
    一种痔疮疾病治疗剂,其活性成分包括式 (I) 的磷酸二酯化合物 其中 R₁ 和 R₂ 相同或不同,且各自为氢原子或甲基,或其药理学上可接受的盐,以及治疗痔疮疾病的方法,包括施用药学上有效量的所述磷酸二酯化合物或其药理学上可接受的盐。
  • Ophthalmic composition
    申请人:Menicon Co., Ltd.
    公开号:EP1308500A1
    公开(公告)日:2003-05-07
    An ophthalmic composition which contains a component A consisting of at least one member selected from the group consisting of polyoxyalkylene block copolymers and their derivatives, and a component B consisting of at least one member selected from the group consisting of caproic acid and its derivatives.
    一种眼科组合物,其中包含至少一种由聚氧亚烷基嵌段共聚物及其衍生物组成的成分 A 和至少一种由己酸及其衍生物组成的成分 B。
  • Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent
    申请人:FERRER INTERNACIONAL, S.A.
    公开号:EP1698336A1
    公开(公告)日:2006-09-06
    Pharmaceutical compositions useful for treating dermal diseases caused by fungi and yeasts with inflammation and/or associated with a bacterial infection. Such compositions contain a therapeutically effective amount of Sertaconazole, or a pharmaceutically acceptable salt, solvate, isomer thereof or mixtures thereof; and a therapeutically effective amount of at least one compound selected from the group consisting of Hydrocortisone, a pharmaceutically acceptable ester of Hydrocortisone, an antibacterial agent or mixtures thereof.
    用于治疗真菌和酵母菌引起的皮肤疾病、炎症和/或与细菌感染有关的疾病的药物组合物。此类组合物含有治疗有效量的舍他康唑或其药学上可接受的盐、溶解物、异构体或其混合物;以及治疗有效量的至少一种选自氢可的松、氢可的松药学上可接受的酯、抗菌剂或其混合物的化合物。
  • ANTIFUNGAL COMPOSITIONS COMPRISING SERTACONAZOL AND HYDROCORTISONE AND/OR AN ANTIBACTERIAL QUINOLONE COMPOUND
    申请人:FERRER INTERNACIONAL, S.A.
    公开号:EP1858510A1
    公开(公告)日:2007-11-28
  • Antifungal Compositions
    申请人:Palacin Celia
    公开号:US20080166398A1
    公开(公告)日:2008-07-10
    Pharmaceutical compositions useful for treating dermal diseases caused by fungi and yeasts with inflammation and/or associated with a bacterial infection. Such compositions contain a therapeutically effective amount of sertaconazole, or a pharmaceutically acceptable salt, solvate, isomer thereof or mixtures thereof; and a therapeutically effective amount of at least one compound selected from the group consisting of hydrocortisone, a pharmaceutically acceptable ester of hydrocortisone, an antibacterial quinolone compound, and mixtures thereof.
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B